Limited Benefit of beta-Blockers After Acute MI With Preserved LVEF, reveals research Dr Riya Dave11 Jan 2026 8:30 PM ISTUse of beta-blockers has been a cornerstone in the treatment era following acute myocardial infarction (MI), especially in the presence of low left...
Clonal Hematopoiesis of Indeterminate Potential Linked to Increased Risk of Heart Failure: JAMA Medha Baranwal7 Jan 2026 9:15 AM ISTUSA: Researchers have found in a new cohort study that clonal hematopoiesis of indeterminate potential (CHIP), particularly non-DNMT3A CHIP, was...
Diabetes drug may reduce irregular heartbeat events in obese adults with AF, reveals study Dr. Kamal Kant Kohli6 Jan 2026 9:00 AM ISTPeople with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes medication metformin in...
Stage B Heart Failure Identified More than Expected in Indian Patients Undergoing Routine Echocardiography: IHJ, October 2025, Study Finds Dr. Bhumika Maikhuri31 Dec 2025 11:00 AM ISTA recent study revealed a high prevalence of stage B heart failure (HF) in a general clinical setting in India. The authors highlighted that...
Calcium in breast arteries predicts future cardiovascular disease, suggests research Dr. Kamal Kant Kohli31 Dec 2025 9:15 AM ISTRoutine mammograms are a critical tool for breast cancer screening. However, they may also hold crucial, potentially untapped information about a...
High-Sensitivity CRP Identified as a Powerful Prognostic Marker in Heart Failure with Reduced Ejection Fraction: AHJ, December 2025 Dr. Bhumika Maikhuri29 Dec 2025 10:00 AM ISTAccording to a recent study, in heart failure with reduced ejection fraction (HFrEF) patients, elevated high-sensitivity C-reactive protein (hs-CRP)...
Gum disease may be linked to plaque buildup in arteries, higher risk of major CVD events: Study Dr. Kamal Kant Kohli23 Dec 2025 8:15 PM IST There is increasing evidence that gum disease is associated with increased risk of cardiovascular events, including heart attack, stroke, atrial...
ACC/AHA issue new guideline on managing congenital heart disease in adults Dr. Kamal Kant Kohli22 Dec 2025 9:00 PM ISTThe American College of Cardiology (ACC) and the American Heart Association, along with several other leading medical associations, have issued a new...
Bayer Finerenone approved in Japan for chronic heart failure Ruchika Sharma22 Dec 2025 10:30 AM ISTBerlin: Bayer has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for finerenone (Kerendia), a non-steroidal, selective...
FDA Approves Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Dr. Kamal Kant Kohli22 Dec 2025 10:30 AM ISTThe US Food and Drug Administration has approved aficamten (Myqorzo), an allosteric cardiac myosin inhibitor, for adults with symptomatic obstructive...
Dapagliflozin vs Empagliflozin Show Similar Clinical Outcomes in HF: JAMA Dr Riya Dave20 Dec 2025 8:45 AM ISTA cohort study in patients with heart failure (HF) found that dapagliflozin and empagliflozin provided comparable clinical outcomes. The authors note...
